COCP Cocrystal Pharma, Inc.: institutional ownership and insider trading
29 funds reported holding $1.43M of Cocrystal Pharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $353K, with 5 new positions and 6 funds selling out; over the last 12 months insiders bought $301K and sold $0 on the open market.
Famous investors holding COCP
- Renaissance Technologies (Renaissance Technologies): $189K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $184K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $47.4K, 0.0% of the portfolio
Largest institutional holders of COCP
- VANGUARD CAPITAL MANAGEMENT LLC — $376K
- VANGUARD GROUP INC — $258K
- RENAISSANCE TECHNOLOGIES LLC — $189K
- TWO SIGMA INVESTMENTS, LP — $184K
- GEODE CAPITAL MANAGEMENT, LLC — $80.0K
- BlackRock, Inc. (BLK) — $77.4K
- CITADEL ADVISORS LLC — $47.4K
- Neuberger Berman Group LLC — $33.5K
- XTX Topco Ltd — $30.8K
- JANE STREET GROUP, LLC — $27.0K
Recent COCP insider trades
- Aug 5, 2026: Frost Phillip Md Et Al bought 10,000 shares ($9.80K)
- Aug 3, 2026: Frost Phillip Md Et Al bought 75,000 shares ($70.5K)
- Feb 24, 2026: Frost Phillip Md Et Al bought 20,000 shares ($20.0K)
- Feb 6, 2026: Frost Phillip Md Et Al bought 50,000 shares ($47.5K)
5%+ owners
- OPKO HEALTH, INC.: 29.6% (Schedule 13D, filed Aug 7, 2026)
- Phillip Frost, M.D.: 13.9% (Schedule 13D/A, filed Aug 7, 2026)